In the present study, pseudocholinesterase turned out to be the best parameter to differentiate between patients with definite WD and patients with suspected WD, who were probably heterozygotic gene carriers and/or suffered from other mainly neurological disease entities. Here, BCHE is linked to nervous system disorder.